Unknown

Dataset Information

0

An open-source, automated, and cost-effective platform for COVID-19 diagnosis and rapid portable genomic surveillance using nanopore sequencing.


ABSTRACT: The COVID-19 pandemic, caused by SARS-CoV-2, has emphasized the necessity for scalable diagnostic workflows using locally produced reagents and basic laboratory equipment with minimal dependence on global supply chains. We introduce an open-source automated platform for high-throughput RNA extraction and pathogen diagnosis, which uses reagents almost entirely produced in-house. This platform integrates our methods for self-manufacturing magnetic nanoparticles and qRT-PCR reagents-both of which have received regulatory approval for clinical use-with an in-house, open-source robotic extraction protocol. It also incorporates our "Nanopore Sequencing of Isothermal Rapid Viral Amplification for Near Real-time Analysis" (NIRVANA) technology, designed for tracking SARS-CoV-2 mutations and variants. The platform exhibits high reproducibility and consistency without cross-contamination, and its limit of detection, sensitivity, and specificity are comparable to commercial assays. Automated NIRVANA effectively identifies circulating SARS-CoV-2 variants. Our in-house, cost-effective reagents, automated diagnostic workflows, and portable genomic surveillance strategies provide a scalable and rapid solution for COVID-19 diagnosis and variant tracking, essential for current and future pandemic responses.

SUBMITTER: Ramos-Mandujano G 

PROVIDER: S-EPMC10663496 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


The COVID-19 pandemic, caused by SARS-CoV-2, has emphasized the necessity for scalable diagnostic workflows using locally produced reagents and basic laboratory equipment with minimal dependence on global supply chains. We introduce an open-source automated platform for high-throughput RNA extraction and pathogen diagnosis, which uses reagents almost entirely produced in-house. This platform integrates our methods for self-manufacturing magnetic nanoparticles and qRT-PCR reagents-both of which h  ...[more]

Similar Datasets

| S-EPMC6348682 | biostudies-literature
| S-EPMC9426752 | biostudies-literature
2022-09-29 | GSE214106 | GEO
2016-04-18 | E-MTAB-4553 | biostudies-arrayexpress
| S-EPMC10869361 | biostudies-literature
| S-EPMC1414086 | biostudies-literature
| S-EPMC9041177 | biostudies-literature
| S-EPMC8172042 | biostudies-literature
| S-EPMC10794453 | biostudies-literature
| S-EPMC9966110 | biostudies-literature